Middle East Healthcare Company (4009.SR)
- Previous Close
93.00 - Open
93.10 - Bid 91.30 x --
- Ask 91.20 x --
- Day's Range
91.10 - 94.00 - 52 Week Range
38.50 - 134.40 - Volume
168,356 - Avg. Volume
734,851 - Market Cap (intraday)
8.385B - Beta (5Y Monthly) 0.49
- PE Ratio (TTM)
46.48 - EPS (TTM)
1.96 - Earnings Date May 13, 2024 - May 17, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date Jun 25, 2018
- 1y Target Est
78.20
Middle East Healthcare Company, a healthcare provider, owns and operates a network of hospitals under the Saudi German Hospital name in the Middle East and North Africa. It also operates, manages, and maintains medical and educational centres, rehabilitation centres, physiotherapy, pharmacies, laboratories, and radiology centres. The company also buys land to construct medical projects, as well as to establish, manage, construct, and organize exhibitions. The company was founded in 1988 and is based in Jeddah, the Kingdom of Saudi Arabia. Middle East Healthcare Company operates as a subsidiary of Bait Al Batterjee Medical Co. Ltd.
saudigermanhealth.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 4009.SR
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4009.SR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4009.SR
Valuation Measures
Market Cap
8.38B
Enterprise Value
10.83B
Trailing P/E
46.48
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.16
Price/Book (mrq)
5.52
Enterprise Value/Revenue
4.08
Enterprise Value/EBITDA
19.88
Financial Highlights
Profitability and Income Statement
Profit Margin
6.79%
Return on Assets (ttm)
4.43%
Return on Equity (ttm)
12.35%
Revenue (ttm)
2.65B
Net Income Avi to Common (ttm)
180.18M
Diluted EPS (ttm)
1.96
Balance Sheet and Cash Flow
Total Cash (mrq)
44.42M
Total Debt/Equity (mrq)
158.82%
Levered Free Cash Flow (ttm)
-267.36M
Research Analysis: 4009.SR
Company Insights: 4009.SR
4009.SR does not have Company Insights